glutathione levels and tbi Neuroforensomics: metabolites as valuable biomarkers in cerebrospinal fluid of lethal traumatic brain injuries Increasing glutathione levels by a

Category 2 is the FDA's designation for bulk drug substances nominated for compounding consideration that have been identified as presenting potential safety risks and are currently ineligible for routine compounding under Section 503A

Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML (2006) Microarray Analysis of Retinal Gene Expression in the DBA/2J Model of Glaucoma

Previously, we showed that TG2 mediates crystallin, caspase 3, and collagen crosslinking in response to oxidative stress, hypoxic stress, and DNA damage, which leads to cataract formation, apoptotic resistance, and fibrotic development, respectively 4,5,6

Here's a straightforward example